Psychological and physiological effects of extended DMT
Lisa Xiaolu Luan, Emma Eckernäs, Michael Ashton, Fernando Rosas, Malin Uthaug, Alexander Bartha, Samantha Jagger, Kiara Gascon-Perai, Lauren Gomes, David Nutt, David Erritzøe, Robin Carhart-Harris, Christopher Timmermann
PsyArXiv April 13, 2023 preprint DOI: 10.31234/osf.io/vg4dp
Summary
AI-generated from the abstractA within-subjects, placebo-controlled study tested a novel method of administering N,N-Dimethyltryptamine (DMT) by combining a bolus injection with a constant-rate infusion to extend the experience to 30 minutes. The method effectively maintained stable and tolerable subjective effects over the infusion period. Anxiety ratings remained low, and heart rate habituated within 15 minutes, indicating psychological and physiological safety. Plasma DMT concentrations increased consistently starting ten minutes into administration, while psychological effects plateaued, suggesting acute psychological tolerance to DMT. These findings demonstrate the safety and effectiveness of continuous intravenous DMT administration for basic and clinical research.
Study at a glance
| Characteristics | Within-subjects, placebo-controlled study |
|---|---|
| Duration | 30-minute infusion period |
| Topics | Altered states of consciousness Philosophy of mind |
| Keywords | DMT Research Dimethyltryptamine study Psychedelic investigation Entheogen research Psychopharmacology study |
| Citations | 9 |
| Key finding | Continuous intravenous DMT administration via bolus injection paired with constant-rate infusion safely extends the DMT experience to 30 minutes with stable subjective effects and low anxiety, while plasma DMT concentrations increase and psychological effects plateau, indicating acute tolerance. |
Abstract
Background: N,N-Dimethyltryptamine (DMT) is a serotonergic psychedelic that when injected as a bolus intravenous injection induces a rapid and transient altered state of consciousness. Its marked and novel subjective effects make DMT a powerful tool for the neuroscientific study of consciousness and preliminary results show its potential role in treating mental health conditions. Aims: In a within-subjects, placebo-controlled study, we investigated a novel method of DMT administration involving a bolus injection paired with a constant-rate infusion, with the goal of extending the DMT experience. Methods: Pharmacokinetic parameters of DMT estimated from plasma data of a previous study of bolus intravenous DMT were used to derive dose regimens necessary to keep subjects in steady levels of immersion into the DMT experience over an extended period of 30 minutes, and four dose regimens were tested. Results: The present method is effective for extending the DMT experience in a stable and tolerable fashion. While subjective effects were maintained over the period of active infusion, anxiety ratings remained low and heart rate habituated within 15 minutes, indicating psychological and physiological safety of extended DMT. Plasma DMT concentrations increased consistently starting ten minutes into DMT administration, whereas psychological effects plateaued into the desired steady state, suggesting the development of acute psychological tolerance to DMT. Conclusion: Taken together, these findings demonstrate the safety and effectiveness of continuous IV DMT administration, laying the groundwork for the further development of this method of administration for basic and clinical research.